(-)-Limonene
(Synonyms: (-)-柠檬烯,(S)-(-)-Limonene) 目录号 : GC38316A monoterpene with diverse biological activities
Cas No.:5989-54-8
Sample solution is provided at 25 µL, 10mM.
(+)-Limonene is a monoterpene that has been found in citrus oils and Cannabis and has diverse biological activities, including anticancer, antimicrobial, antioxidant, anti-inflammatory, and chemoprotective properties.1,2,3,4 It inhibits the growth of bacteria including S. aureus, B. cereus, E. faecalis, E. coli, P. aeruginosa, K. pneumoniae, M. catarrhalis, and C. neoformans with MIC values ranging from 3 to 27 mg/ml.1 In a human BGC-823 gastric cancer nude mouse orthotopic transplantation model, (+)-limonene inhibits tumor growth by 47.6% compared to controls and reduces the number of metastases in the liver, peritoneum, and other organs when administered by gastric perfusion at a dose of 15 ml/kg of a 1% emulsion.5 Dietary administration of (+)-limonene (5 and 10% in chow) reverses doxorubicin-induced decreases in glutathione (GSH) levels in rat kidney.3 Formulations containing (+)-limonene have been used as flavoring and fragrance agents and in the treatment of gallstones, heartburn, and gastroesophageal reflux disorder.
1.van Vuuren, S.F., and Viljoen, A.M.Antimicrobial activity of limonene enantiomers and 1,8-cineole alone and in combinationFlavor and Frag. J.22(6)540-544(2007) 2.Sun, J.D-Limonene: Safety and clinical applicationsAltern. Med. Rev.12(3)259-264(2007) 3.Rehman, M.U., Tahir, M., Khan, A.Q., et al.D-limonene suppresses doxorubicin-induced oxidative stress and inflammation via repression of COX-2, iNOS, and NFκB in kidneys of Wistar ratsExp. Biol. Med. (Maywood)239(4)465-476(2014) 4.Handbook of Cannabis therapeutics from bench to bedside(2010) 5.Lu, X.-G., Zhan, L.-B., Feng, B.-A., et al.Inhibition of growth and metastasis of human gastric cancer implanted in nude mice by d-limoneneWorld J. Gastroenterol.10(14)2140-2144(2004)
Cas No. | 5989-54-8 | SDF | |
别名 | (-)-柠檬烯,(S)-(-)-Limonene | ||
Canonical SMILES | CC1=CC[C@@H](C(C)=C)CC1 | ||
分子式 | C10H16 | 分子量 | 136.23 |
溶解度 | DMF: 20 mg/ml,DMSO: 20 mg/ml,Ethanol: 20 mg/ml,Ethanol:PBS (pH 7.2)(1:2): 0.33 mg/ml | 储存条件 | 4°C, protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 7.3405 mL | 36.7026 mL | 73.4053 mL |
5 mM | 1.4681 mL | 7.3405 mL | 14.6811 mL |
10 mM | 0.7341 mL | 3.6703 mL | 7.3405 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet